Acute chest syndrome and COVID‐19 in hydroxyurea naïve sickle cell disease patient in a low resource setting

Acute chest syndrome and COVID‐19 in hydroxyurea naïve sickle cell disease patient in a low resource setting

Abstract Acute chest syndrome (ACS) is a severe complication of sickle cell disease (SCD) and one of the leading causes of mortality in SCD patients. The management of ACS is challenging and requires prompt intervention to halt clinical deterioration. With the outbreak of the Coronavirus Disease 201...

Full description

Bibliographic Details
Main Authors: William Frank Mawalla, Ahlam Nasser, James Salumu Jingu, Happiness Joseph, Lilian Gasper Mmbaga, Eunice Shija, Helena Kakumbula, Neema Budodi Lubuva, Collins Meda, Clara Chamba
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:eJHaem
Subjects:
acute chest syndrome
case report
COVID 19
hydroxyurea
SARS‐Cov‐2
sickle cell disease
Online Access:https://doi.org/10.1002/jha2.397

Internet

https://doi.org/10.1002/jha2.397

Similar Items